WFI
DNA icon

West Family Investments’s Ginkgo Bioworks DNA Stock Holding History

West Family Investments’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-644
Closed -$43.5K – 233
2022
Q4 		$43.5K Buy
+644
New +$59.2K 0.01% 233

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

West Family Investments's DNA Position: Q1 2023 in Review

West Family Investments sold out of Ginkgo Bioworks (DNA) in Q1 2023, closing a stake of 644 shares — an estimated $43.5K sold.

West Family Investments first reported a position in DNA in Q4 2022 and held it in 1 quarter. The position peaked at $43.5K in Q4 2022. 313 funds tracked by Wall St. Rank hold DNA as of Q1 2023.

  • West Family Investments reported no remaining Ginkgo Bioworks position as of Q1 2023 after selling out during the quarter.
  • West Family Investments sold 644 Ginkgo Bioworks shares in Q1 2023, an estimated $43.5K.
  • West Family Investments first reported a position in Ginkgo Bioworks in Q4 2022 and held it in 1 quarter.
  • West Family Investments's Ginkgo Bioworks position peaked at $43.5K in Q4 2022.
  • 313 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2023.

Based on West Family Investments's 13F filing for Q1 2023, filed 3 May 2023.